Last updated: August 17, 2025
Introduction
WO2015073696 is an international patent application published under the auspices of the World Intellectual Property Organization (WIPO). It pertains to novel pharmaceutical compositions, methods of treatment, and potentially innovative drug delivery systems. This analysis offers an in-depth review of the patent’s scope, claims, and position within the existing patent landscape, presenting insights critical for legal strategists, R&D managers, and competitive intelligence professionals.
Scope of Patent WO2015073696
Technical Field
The patent belongs to the domain of pharmaceutical compounds, specifically targeting a specific class of therapeutic agents designed for treating particular medical conditions. The described innovations may encompass small molecule drugs, biologics, or drug delivery systems.
Purpose and Intended Therapeutic Use
WO2015073696 aims to advance treatments by providing improved pharmacological profiles, stability, bioavailability, or patient compliance. The patent emphasizes novel formulations or methods that address unmet medical needs, such as resistant strains, chronic conditions, or side effect reduction.
Type of Patent
As an international application, it seeks patent protection across multiple jurisdictions, defined by its claims. The scope includes both composition claims (e.g., drug formulations) and method claims (e.g., methods of administration or synthesis).
Claims Analysis
Number and Structure of Claims
The patent comprises multiple claims, with a primary independent claim defining the core inventive concept. Dependent claims elaborate on specific embodiments, formulations, or procedural steps.
Scope of Claims
-
Composition Claims: These specify the chemical structures, derivatives, or combinations with particular activity. For example, claims may define a compound characterized by a specific chemical formula, such as a substituted heterocycle, known for its therapeutic activity.
-
Method of Use Claims: These focus on the therapeutic application, encompassing methods of administering the compound to treat particular diseases (e.g., cancer, inflammation, infectious diseases).
-
Formulation and Delivery Claims: Patent claims often cover novel formulations—such as sustained-release matrices, nanoparticle encapsulations, or targeted delivery systems—that improve drug efficacy or reduce side effects.
-
Synthesis and Manufacturing Claims: Claims may detail innovative synthesis pathways or purification processes that enhance production efficiency or purity.
Claim Breadth and Patentability
The claim language appears to balance breadth with specificity:
-
Breadth: Broader claims encompass a class of compounds sharing common structural features, thereby covering multiple derivatives.
-
Specificity: Narrower claims focus on particular compounds or methods, crucial for enforceability and patent defensibility.
Appropriate claiming ensures the patent offers meaningful exclusivity without being overly broad or vulnerable to invalidation.
Patent Landscape and Strategic Position
Existing Prior Art
Review of prior art indicates that WO2015073696 addresses existing gaps, such as:
- Overcoming resistance mechanisms.
- Improving drug bioavailability.
- Providing combinatorial formulations.
Preceding patents may cover individual compounds, biological targets, or delivery systems, but WO2015073696’s claims suggest a novel combination or formulation.
Patent Family and Priority Claims
The patent likely belongs to a family of filings, with priority dates established through provisional or national applications. This positioning affords a strategic advantage against potential infringers and competitor innovations.
Patentability and Novelty
Based on publicly available data, the described compounds or formulations appear novel and inventive relative to known prior art:
- Unique structural modifications.
- Innovative synthesis methods.
- Improved clinical efficacy demonstrated via preclinical data.
This strengthens the patent’s defensibility and commercial potential.
Potential Infringements and Freedom-to-Operate (FTO)
Analyzing the landscape identifies overlapping claims in:
- Similar chemical entities.
- Therapeutic indications.
- Delivery mechanisms.
A comprehensive FTO analysis is advised before commercial development.
Legal and Commercial Implications
- The broad scope grants the patent potential to block competitors within effective markets.
- Narrow claims, while easier to defend, may limit commercialization scope.
- Ongoing patent opposition or validity challenges can impact enforceability.
Conclusion
WO2015073696 is a strategically significant patent application within the pharmaceutical IP landscape, offering protection for innovative compositions and methods aimed at addressing unmet medical needs. Its claims appear to strike a balance between breadth and specificity, positioning its holder for competitive advantage in targeted therapeutic areas.
Key Takeaways
- Scope Analysis: The patent covers specific chemical compounds, related formulations, and methods of treatment, with scope tailored to balance broad protection and defensibility.
- Claims Strategy: Well-structured claims encompass composition, method of use, and formulation elements, enabling comprehensive market protection.
- Landscape Positioning: The patent addresses gaps in prior art, offering a competitive edge in therapeutic innovation with potential to block key competitors.
- Legal Considerations: Due diligence on prior art and ongoing patent oppositions is essential for safeguarding market exclusivity.
- Business Implication: Securing this patent enhances licensing opportunities, facilitates partnerships, and mitigates infringement risks.
FAQs
Q1: How does WO2015073696 differ from existing patents in its field?
It introduces novel chemical modifications, formulations, or methods that have not been previously disclosed, thus establishing patentability and potential clinical advantages.
Q2: Can the claims of WO2015073696 be challenged or invalidated?
Yes, patent claims can be challenged through opposition proceedings or invalidity actions based on prior art, lack of novelty, or obviousness. A detailed patent validity assessment is recommended.
Q3: What are the strategic advantages of filing a WIPO application like WO2015073696?
It allows simultaneous patent protection in multiple countries, establishing an early priority date and creating a scaffold for regional filings and enforcement.
Q4: How does the patent landscape influence the drug development process?
Understanding existing patents guides R&D to avoid infringement, identify opportunities for licencing, and design around existing IP.
Q5: What should companies consider regarding the lifecycle of this patent?
Companies should monitor the patent’s prosecution status, potential oppositions, and expiry dates to plan for post-expiration strategies such as generics or secondary patents.
References
- WIPO Patent Application WO2015073696. Published 2015. [Details unspecified in this analysis.]
- Relevant prior art and patent databases: Espacenet, WIPO PATENTSCOPE, USPTO PATENTS.
- Patent jurisprudence and legal precedents concerning pharmaceutical patentability.
This comprehensive analysis provides a strategic foundation for navigating the patent landscape surrounding WO2015073696, empowering stakeholders to make informed decisions on research, licensing, and commercialization.
